About HUMA.AI
HUMA.AI is a company based in Palo Alto (United States) founded in 2018 by Lana Feng and Greg Kostello. HUMA.AI has raised $15.01 million across 5 funding rounds from investors including Human Longevity, Excelerate Health Ventures and Hatteras Venture Partners. HUMA.AI offers products and services including Insight Surfacing, Literature Review, Evidence Generation, and CRM Analysis. HUMA.AI operates in a competitive market with competitors including IQVIA, Dental Intel, AVIA, Hublo and Advisory, among others.
- Headquarter Palo Alto, United States
- Founders Lana Feng, Greg Kostello
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Huma Ai Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.01 M (USD)
in 5 rounds
-
Latest Funding Round
$1.02 M (USD), Series A
Mar 25, 2025
-
Investors
Human Longevity
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HUMA.AI
HUMA.AI offers a comprehensive portfolio of products and services, including Insight Surfacing, Literature Review, Evidence Generation, and CRM Analysis.
Platform for gathering key takeaways and trends from data sources.
Automates research queries for accurate and timely results.
Confirms findings with traceable data across sources.
Consolidates and analyzes CRM data for insights.
People of HUMA.AI
Unlock access to complete
Unlock access to complete
Funding Insights of HUMA.AI
HUMA.AI has successfully raised a total of $15.01M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $1.02 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in HUMA.AI
HUMA.AI has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Human Longevity, Excelerate Health Ventures and Hatteras Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided for AI-driven healthcare innovations.
|
Locked | Locked | Locked | |
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Locked | Locked | Locked | |
|
US-focused private equity and venture capital investments are managed.
|
Locked | Locked | Locked |
Investor details for HUMA.AI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HUMA.AI
Investment portfolio details for HUMA.AI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HUMA.AI
Detailed financials for HUMA.AI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Huma.Ai Comparisons
Peer comparison for HUMA.AI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HUMA.AI
HUMA.AI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IQVIA, Dental Intel, AVIA, Hublo and Advisory, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical research and commercialization solutions are provided for healthcare.
|
|
| Locked | Locked | Locked |
Dental intelligence is delivered via SaaS platform for performance analytics.
|
|
| Locked | Locked | Locked |
Digital platform for healthcare management and networking is offered.
|
|
| Locked | Locked | Locked |
Platform for hospitals to manage staff recruitments and replacements
|
|
| Locked | Locked | Locked |
Analytics platforms and consulting services for business intelligence are offered.
|
|
| Locked | Locked | Locked |
A real-time care orchestration platform for healthcare systems is provided by DexCare.
|
Detailed competitors of HUMA.AI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Huma.Ai
Complete news archive for HUMA.AI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HUMA.AI
HUMA.AI was founded in 2018 and raised its 1st funding round 1 year after it was founded.
HUMA.AI is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Lana Feng is the current CEO of HUMA.AI. They have also founded this company.
HUMA.AI is a funded company, having raised a total of $15.01M across 5 funding rounds to date.
HUMA.AI was founded in 2018 and is headquartered in Palo Alto, United States. Operations focus on the healthcare sector, where AI-based tools are provided for business development. Software capabilities encompass business intelligence, interoperable data handling, clinical documentation support, and medical affairs management. These features facilitate data integration and operational efficiency in healthcare environments.
HUMA.AI offers Insight Surfacing, Literature Review, Evidence Generation, and CRM Analysis.
HUMA.AI has 10 investors. Key investors include Human Longevity, Excelerate Health Ventures, Hatteras Venture Partners, Boston Millennia Partners, and SteelSky Ventures.